142 related articles for article (PubMed ID: 24713092)
1. Evaluation of genetic biomarkers for distinguishing benign from malignant thyroid neoplasms.
Nagar S; Ahmed S; Peeples C; Urban N; Boura J; Thibodeau B; Akervall J; Wilson G; Long G; Czako P
Am J Surg; 2014 Apr; 207(4):596-601. PubMed ID: 24713092
[TBL] [Abstract][Full Text] [Related]
2. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.
Jin L; Lloyd RV; Nassar A; Lappinga PJ; Sebo TJ; Swartz K; Seys AR; Erickson-Johnson MR; Roth CW; Evers BR; Oliveira AM; Zhang J
Diagn Mol Pathol; 2011 Jun; 20(2):71-80. PubMed ID: 21532495
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
[TBL] [Abstract][Full Text] [Related]
4. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.
Liou MJ; Chan EC; Lin JD; Liu FH; Chao TC
Cancer Lett; 2003 Mar; 191(2):223-7. PubMed ID: 12618337
[TBL] [Abstract][Full Text] [Related]
5. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms.
Saji M; Xydas S; Westra WH; Liang CK; Clark DP; Udelsman R; Umbricht CB; Sukumar S; Zeiger MA
Clin Cancer Res; 1999 Jun; 5(6):1483-9. PubMed ID: 10389936
[TBL] [Abstract][Full Text] [Related]
6. Classification of follicular thyroid tumors by molecular signature: results of gene profiling.
Barden CB; Shister KW; Zhu B; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ
Clin Cancer Res; 2003 May; 9(5):1792-800. PubMed ID: 12738736
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization.
Kammori M; Nakamura K; Hashimoto M; Ogawa T; Kaminishi M; Takubo K
Int J Oncol; 2003 May; 22(5):985-91. PubMed ID: 12684663
[TBL] [Abstract][Full Text] [Related]
8. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.
Zeiger MA; Smallridge RC; Clark DP; Liang CK; Carty SE; Watson CG; Udelsman R; Saji M
Surgery; 1999 Dec; 126(6):1195-8; discussion 1198-9. PubMed ID: 10598207
[TBL] [Abstract][Full Text] [Related]
9. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T
Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; McMillan A
Cancer; 2006 Jun; 106(12):2592-7. PubMed ID: 16688775
[TBL] [Abstract][Full Text] [Related]
11. Genetic markers to discriminate benign and malignant thyroid nodules with undetermined cytology in an area of borderline iodine deficiency.
Tonacchera M; Agretti P; Rago T; De Marco G; Niccolai F; Molinaro A; Scutari M; Candelieri A; Conforti D; Musmanno R; Di Coscio G; Basolo F; Iacconi P; Miccoli P; Pinchera A; Vitti P
J Endocrinol Invest; 2012 Sep; 35(8):754-9. PubMed ID: 21979329
[TBL] [Abstract][Full Text] [Related]
12. STT3A, C1orf24, TFF3: putative markers for characterization of follicular thyroid neoplasms from fine-needle aspirates.
Patel MR; Stadler ME; Deal AM; Kim HS; Shores CG; Zanation AM
Laryngoscope; 2011 May; 121(5):983-9. PubMed ID: 21520112
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity in "suspicious" thyroid cytology.
Lerma E; Mora J
Cancer; 2005 Dec; 105(6):492-7. PubMed ID: 16104043
[TBL] [Abstract][Full Text] [Related]
14. Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules.
Siddiqui MT; Greene KL; Clark DP; Xydas S; Udelsman R; Smallridge RC; Zeiger MA; Saji M
Diagn Mol Pathol; 2001 Jun; 10(2):123-9. PubMed ID: 11385322
[TBL] [Abstract][Full Text] [Related]
15. Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors.
Umbricht CB; Conrad GT; Clark DP; Westra WH; Smith DC; Zahurak M; Saji M; Smallridge RC; Goodman S; Zeiger MA
Clin Cancer Res; 2004 Sep; 10(17):5762-8. PubMed ID: 15355904
[TBL] [Abstract][Full Text] [Related]
16. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
[TBL] [Abstract][Full Text] [Related]
17. Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin alpha and parathymosin in thyroid: novel proliferation markers?
Letsas KP; Vartholomatos G; Tsepi C; Tsatsoulis A; Frangou-Lazaridis M
Neoplasma; 2007; 54(1):57-62. PubMed ID: 17203893
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity in fine needle aspiration biopsy samples: application to diagnosis of human thyroid carcinoma.
Guerra LN; Miler EA; Moiguer S; Karner M; Orlandi AM; Fideleff H; Burdman JA
Clin Chim Acta; 2006 Aug; 370(1-2):180-4. PubMed ID: 16600201
[TBL] [Abstract][Full Text] [Related]
19. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]